NeuraCap review
A market-comparables platform with valuation ranges and exportable reports, but no DCF evidence.
Reviewed by iTechGuides Editors · Editorial team · Updated Nov 2026
NeuraCap is a financial analysis platform for business brokers, M&A advisers, valuation professionals and other deal professionals. It evaluates public companies and private companies using comparable-company analysis, precedent transactions, sector benchmarks and market data. Its emphasis is on market evidence and valuation ranges, making it a fit for advisers who need to compare a business with peers and transactions rather than build a broader valuation from multiple method families.
The analysis combines trading comparables using EV/EBITDA and EV/Revenue, forward multiples based on consensus estimates, and precedent M&A transaction analysis. Peer, financial and industry KPI benchmarking adds context, while a football-field chart presents valuation ranges across methods. For private-company evaluation, users provide financial and operating data, which NeuraCap enriches with market context. Its Financial Assistant can answer questions about the analysis. These features support a market-based workflow, but the supplied feature scope does not include DCF or asset-based methods; teams that require those approaches should consider a tool with that coverage.
NeuraCap separates free research from its quote-based platform. The free Coverage plan includes industry sector outlook reports and bi-weekly industry events and M&A updates. The Platform plan adds public company analysis, private company evaluation, valuation analysis, football-field charts, and PDF and PPTX report export; pricing is by contacting sales. It is cloud-based and web-accessible, with email support. NeuraCap describes its reports as analytical tools, not formal appraisals or fairness opinions, so it is better suited to deal professionals seeking decision-support analysis than to buyers needing a formal appraisal or fairness opinion.
NeuraCap pros and cons
- Where it wins
- Trading comparables include EV/EBITDA and EV/Revenue multiples
- Combines forward multiples, precedent transactions and KPI benchmarking
- Presents valuation ranges in football-field charts and exports PDF or PPTX
- Where it doesn't
- The free Coverage plan is limited to industry research
- Platform access is quote-based rather than published as a set price
- Supplied feature details do not include DCF or asset-based valuation methods
NeuraCap fact sheet, pricing and score →
Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.
Last updated · How we research and update